Astec LifeSciences Limited

NSEI:ASTEC Stok Raporu

Piyasa değeri: ₹21.2b

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Astec LifeSciences Yönetim

Yönetim kriter kontrolleri 3/4

Astec LifeSciences' CEO'su Anurag Roy, Jul2021 tarihinde atandı, in görev süresi 3.25 yıldır. in toplam yıllık tazminatı ₹ 23.80M olup, şirket hissesi ve opsiyonları dahil olmak üzere 89.2% maaş ve 10.8% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.006% ine doğrudan sahiptir ve bu hisseler ₹ 1.31M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3.3 yıl ve 4.3 yıldır.

Anahtar bilgiler

Anurag Roy

İcra Kurulu Başkanı

₹23.8m

Toplam tazminat

CEO maaş yüzdesi89.2%
CEO görev süresi3.3yrs
CEO sahipliği0.006%
Yönetim ortalama görev süresi3.3yrs
Yönetim Kurulu ortalama görev süresi3.8yrs

Son yönetim güncellemeleri

Shareholders May Be Wary Of Increasing Astec LifeSciences Limited's (NSE:ASTEC) CEO Compensation Package

Jul 23
Shareholders May Be Wary Of Increasing Astec LifeSciences Limited's (NSE:ASTEC) CEO Compensation Package

Recent updates

Shareholders May Be Wary Of Increasing Astec LifeSciences Limited's (NSE:ASTEC) CEO Compensation Package

Jul 23
Shareholders May Be Wary Of Increasing Astec LifeSciences Limited's (NSE:ASTEC) CEO Compensation Package

Market Participants Recognise Astec LifeSciences Limited's (NSE:ASTEC) Revenues Pushing Shares 28% Higher

Jul 03
Market Participants Recognise Astec LifeSciences Limited's (NSE:ASTEC) Revenues Pushing Shares 28% Higher

Astec LifeSciences Limited (NSE:ASTEC) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable

Mar 15
Astec LifeSciences Limited (NSE:ASTEC) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable

Astec LifeSciences (NSE:ASTEC) Could Be Struggling To Allocate Capital

May 17
Astec LifeSciences (NSE:ASTEC) Could Be Struggling To Allocate Capital

Shareholders Are Optimistic That Astec LifeSciences (NSE:ASTEC) Will Multiply In Value

Oct 14
Shareholders Are Optimistic That Astec LifeSciences (NSE:ASTEC) Will Multiply In Value

We Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease

Jul 27
We Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease

Here's Why Astec LifeSciences (NSE:ASTEC) Can Manage Its Debt Responsibly

Jun 28
Here's Why Astec LifeSciences (NSE:ASTEC) Can Manage Its Debt Responsibly

A Look At The Intrinsic Value Of Astec LifeSciences Limited (NSE:ASTEC)

Jun 03
A Look At The Intrinsic Value Of Astec LifeSciences Limited (NSE:ASTEC)

Analysts Just Published A Bright New Outlook For Astec LifeSciences Limited's (NSE:ASTEC)

May 08
Analysts Just Published A Bright New Outlook For Astec LifeSciences Limited's (NSE:ASTEC)

Astec LifeSciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

May 06
Astec LifeSciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)

Jan 25
Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)

Is Astec LifeSciences (NSE:ASTEC) A Risky Investment?

Dec 13
Is Astec LifeSciences (NSE:ASTEC) A Risky Investment?

We Take A Look At Why Astec LifeSciences Limited's (NSE:ASTEC) CEO Has Earned Their Pay Packet

Jul 21
We Take A Look At Why Astec LifeSciences Limited's (NSE:ASTEC) CEO Has Earned Their Pay Packet

Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?

May 02
Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?

The Trend Of High Returns At Astec LifeSciences (NSE:ASTEC) Has Us Very Interested

Apr 17
The Trend Of High Returns At Astec LifeSciences (NSE:ASTEC) Has Us Very Interested

Do Astec LifeSciences's (NSE:ASTEC) Earnings Warrant Your Attention?

Apr 02
Do Astec LifeSciences's (NSE:ASTEC) Earnings Warrant Your Attention?

Is Astec LifeSciences Limited's (NSE:ASTEC) Shareholder Ownership Skewed Towards Insiders?

Mar 18
Is Astec LifeSciences Limited's (NSE:ASTEC) Shareholder Ownership Skewed Towards Insiders?

Have Insiders Been Selling Astec LifeSciences Limited (NSE:ASTEC) Shares?

Mar 05
Have Insiders Been Selling Astec LifeSciences Limited (NSE:ASTEC) Shares?

Did You Miss Astec LifeSciences' (NSE:ASTEC) Whopping 481% Share Price Gain?

Feb 20
Did You Miss Astec LifeSciences' (NSE:ASTEC) Whopping 481% Share Price Gain?

A Look At Astec LifeSciences' (NSE:ASTEC) CEO Remuneration

Feb 08
A Look At Astec LifeSciences' (NSE:ASTEC) CEO Remuneration

Declining Stock and Solid Fundamentals: Is The Market Wrong About Astec LifeSciences Limited (NSE:ASTEC)?

Jan 28
Declining Stock and Solid Fundamentals: Is The Market Wrong About Astec LifeSciences Limited (NSE:ASTEC)?

What Does Astec LifeSciences Limited's (NSE:ASTEC) Share Price Indicate?

Jan 17
What Does Astec LifeSciences Limited's (NSE:ASTEC) Share Price Indicate?

Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)

Jan 08
Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)

I Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease

Dec 28
I Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease

Is Astec LifeSciences Limited (NSE:ASTEC) Popular Amongst Insiders?

Dec 18
Is Astec LifeSciences Limited (NSE:ASTEC) Popular Amongst Insiders?

Astec LifeSciences (NSE:ASTEC) Is Growing Earnings But Are They A Good Guide?

Dec 07
Astec LifeSciences (NSE:ASTEC) Is Growing Earnings But Are They A Good Guide?

Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?

Nov 27
Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?

CEO Tazminat Analizi

Anurag Roy'un ücretlendirmesi Astec LifeSciences'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-₹785m

Mar 31 2024₹24m₹21m

-₹469m

Dec 31 2023n/an/a

-₹509m

Sep 30 2023n/an/a

-₹258m

Jun 30 2023n/an/a

₹60m

Mar 31 2023₹29m₹26m

₹256m

Dec 31 2022n/an/a

₹736m

Sep 30 2022n/an/a

₹975m

Jun 30 2022n/an/a

₹883m

Mar 31 2022₹16m₹15m

₹899m

Tazminat ve Piyasa: Anurag 'nin toplam tazminatı ($USD 283.45K ), Indian pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 184.73K ).

Tazminat ve Kazançlar: Anurag 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.


CEO

Anurag Roy (50 yo)

3.3yrs

Görev süresi

₹23,803,000

Tazminat

Mr. Anurag Roy serves as Chief Executive Officer and Whole Time Director at Astec LifeSciences Limited since July 28, 2021. He served as Growth Unit Head of Advance Intermediates & Vitamins at Jubilant Org...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Anurag Roy
CEO & Whole Time Director3.3yrs₹23.80m0.0056%
₹ 1.2m
Mugdha Khare
Chief Financial Officerless than a yearVeri yokVeri yok
Arijit Mukherjee
Chief Operating Officer3.3yrs₹5.02mVeri yok
Tejashree Pradhan
Company Secretary & Compliance Officer5.9yrs₹1.90mVeri yok
C. Kirubasekaran
Vice President of Marketingno dataVeri yokVeri yok
Tarun Surya
GM of salesno dataVeri yokVeri yok
Vivek Verma
GM of Operationsno dataVeri yokVeri yok

3.3yrs

Ortalama Görev Süresi

Deneyimli Yönetim: ASTEC 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.3 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Anurag Roy
CEO & Whole Time Director3.3yrs₹23.80m0.0056%
₹ 1.2m
Nadir Godrej
Non-Executive Chairman9yrsVeri yokVeri yok
Balram Yadav
Non-Executive Non-Independent Director9yrsVeri yokVeri yok
Ashok Hiremath
Non-Executive Non-Independent Director30.8yrs₹25.42m1.99%
₹ 423.2m
Ganapati Yadav
Independent Directorless than a yearVeri yokVeri yok
Rishinaradamangalam Govindan
Non-Executive Independent Director4.8yrs₹950.00kVeri yok
Nandkumar Dhekne
Non-Executive Independent Director3.8yrs₹400.00kVeri yok
Anjali Gupte
Non-Executive Independent Director3.8yrs₹400.00kVeri yok
Burjis Godrej
Additional Non-Executive Non- Independent Director2.3yrsVeri yokVeri yok

3.8yrs

Ortalama Görev Süresi

67yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: ASTEC 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4.3 yıldır).